|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07F 9/24 | (2006.01) |
| A61P 25/28 | (2006.01) | ||
| A61K 31/661 | (2006.01) |
| (11) | Number of the document | 2841438 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13722201.4 |
| Date of filing the European patent application | 2013-04-26 | |
| (97) | Date of publication of the European application | 2015-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-10 |
| (46) | Date of publication of the claims translation | 2016-11-10 |
| (86) | Number | PCT/US2013/038458 |
| Date | 2013-04-26 |
| (87) | Number | WO 2013/163576 |
| Date | 2013-10-31 |
| (30) | Number | Date | Country code |
| 201261639602 P | 2012-04-27 | US |
| (72) |
VAINO, Andrew, US
BIESTEK, Marek, US
SHKRELI, Martin, US
|
| (73) |
Retrophin, Inc.,
777 Third Avenue 22nd Floor, New York, NY 10017,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pantotenato dariniai, skirti neurologinių sutrikimų gydymui |
| PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2019-04-02 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-04-26 |